Search

Author/Creator Francescone, Mark

1. Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial. Issue 2 (February 2018)

Authors:
O'Connor, Owen A; Lue, Jennifer K; Sawas, Ahmed; Amengual, Jennifer E; Deng, Changchun; Kalac, Matko; Falchi, Lorenzo; Marchi, Enrica; Turenne, Ithamar; Lichtenstein, Renee; Rojas, Celeste; Francescone, Mark; Schwartz, Lawrence; Cheng, Bin; Savage, Kerry J; Villa, Diego; Crump, Michael; Prica, An...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 2(2018)
Page Start:
257
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial. Issue 2 (February 2018)

Authors:
O'Connor, Owen A; Lue, Jennifer K; Sawas, Ahmed; Amengual, Jennifer E; Deng, Changchun; Kalac, Matko; Falchi, Lorenzo; Marchi, Enrica; Turenne, Ithamar; Lichtenstein, Renee; Rojas, Celeste; Francescone, Mark; Schwartz, Lawrence; Cheng, Bin; Savage, Kerry J; Villa, Diego; Crump, Michael; Prica, An...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 2(2018)
Page Start:
257
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search